Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Liver Involvement in POLG Disease-a Multicentre Cohort Study of 202 Patients.

Journal of inherited metabolic disease·2025

Same author

Cognitive impairment profile in patients with the m.3243A> G variant in mitochondrial DNA.

BMC neurology·2025

Same author

FGF14 (GAA∙TTC) repeat expansion-related ataxia SCA27B is common in Northern Finland.

Parkinsonism & related disorders·2025

Same author

Facilitators, Barriers, and Possible Solutions to Improve the Quality of Counselling in Patients With Cerebrovascular Diseases: A Descriptive Qualitative Study.

Scandinavian journal of caring sciences·2025

Same author

Perspectives of Clients and Health Care Professionals on the Opportunities for Digital Health Interventions in Cerebrovascular Disease Care: Qualitative Descriptive Study.

Journal of medical Internet research·2024

Same author

Computerized decision support to optimally funnel patients through the diagnostic pathway for dementia.

Alzheimer's research & therapy·2024

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Amyloid myopathy: a diagnostic challenge.

Heli Tuomaala¹, Mikko Kärppä, Hannu Tuominen

¹Department of Neurology, University of Oulu.

Neurology International

|May 18, 2011

Summary

Amyloid myopathy (AM), a rare systemic amyloidosis complication, can mimic inclusion body myositis. Diagnosis requires careful re-examination of muscle biopsies for amyloid deposits.

Keywords:

amyloid myopathy amyloidosis congo red magnetic resonance imaging myopathy

More Related Videos

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Published on: October 30, 2010

Related Experiment Videos

Last Updated: Jun 1, 2026

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Published on: October 30, 2010

Area of Science:

Neurology
Rheumatology
Pathology

Background:

Amyloid myopathy (AM) is a rare manifestation of primary systemic amyloidosis (AL).
AM presents similarly to inflammatory myopathies with proximal muscle weakness and elevated creatine kinase.
It can be misdiagnosed due to overlapping clinical features.

Purpose of the Study:

To describe a case of AL presenting initially with severe, rapidly progressive myopathy.
To highlight the diagnostic challenges and the importance of specific staining in AM.
To illustrate how AM can clinically mimic inclusion body myositis.

Main Methods:

Case report of a patient with severe myopathy.
Clinical evaluation, muscle biopsy, and gastric mucosal biopsy.
Re-examination of muscle biopsy with Congo red staining for amyloid.

Main Results:

The patient presented with symptoms mimicking inclusion body myositis.
Amyloidosis was confirmed via gastric mucosal biopsy.
Specific re-examination of the muscle biopsy revealed vascular and interstitial amyloid accumulation, confirming AM.

Conclusions:

Amyloid myopathy can present with a clinical picture indistinguishable from inclusion body myositis.
Gastric mucosal biopsy can be crucial for diagnosing systemic amyloidosis when myopathy is the initial symptom.
Careful histological examination of muscle tissue, including specific amyloid stains, is essential for accurate AM diagnosis.